Search for other papers by Jülide Durmuşoğlu in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
Search for other papers by Johan F Langenhuijsen in
Google Scholar
PubMed
Search for other papers by Ad R M M Hermus in
Google Scholar
PubMed
Search for other papers by Annenienke C van de Ven in
Google Scholar
PubMed
hormone-specific symptoms and signs in patients ( 9 ). The most common clinical presentation of functional ACC is Cushing’s syndrome ( 9 , 10 , 11 ). Venous thromboembolism (VTE) is a potential fatal complication ( 12 ). One might expect a high
Search for other papers by M Cherenko in
Google Scholar
PubMed
Search for other papers by N M Appelman-Dijkstra in
Google Scholar
PubMed
Search for other papers by A L Priego Zurita in
Google Scholar
PubMed
Search for other papers by N R Biermasz in
Google Scholar
PubMed
Search for other papers by O M Dekkers in
Google Scholar
PubMed
Search for other papers by F A Klok in
Google Scholar
PubMed
Search for other papers by N Reisch in
Google Scholar
PubMed
Search for other papers by A Aulinas in
Google Scholar
PubMed
Search for other papers by B Biagetti in
Google Scholar
PubMed
Search for other papers by S Cannavo in
Google Scholar
PubMed
Search for other papers by L Canu in
Google Scholar
PubMed
Search for other papers by M Detomas in
Google Scholar
PubMed
Search for other papers by F Devuyst in
Google Scholar
PubMed
Search for other papers by H Falhammar in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by F Ferrau in
Google Scholar
PubMed
Search for other papers by F Gatto in
Google Scholar
PubMed
Search for other papers by C Grasselli in
Google Scholar
PubMed
Search for other papers by P van Houten in
Google Scholar
PubMed
Search for other papers by C Hoybye in
Google Scholar
PubMed
Search for other papers by A M Isidori in
Google Scholar
PubMed
Search for other papers by A Kyrilli in
Google Scholar
PubMed
Search for other papers by P Loli in
Google Scholar
PubMed
Search for other papers by D Maiter in
Google Scholar
PubMed
Search for other papers by E Nowak in
Google Scholar
PubMed
Search for other papers by R Pivonello in
Google Scholar
PubMed
Search for other papers by O Ragnarsson in
Google Scholar
PubMed
Search for other papers by R V Steenaard in
Google Scholar
PubMed
Search for other papers by N Unger in
Google Scholar
PubMed
Search for other papers by A van de Ven in
Google Scholar
PubMed
Search for other papers by S M Webb in
Google Scholar
PubMed
Search for other papers by D Yeste in
Google Scholar
PubMed
University of Glasgow, Office for Rare Conditions, Glasgow, UK
University of Glasgow, Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by A M Pereira in
Google Scholar
PubMed
%) 41 (59.4%) 10 (83.3%) 154 (69.3%) Surgery: n (%) 133 (94.3%) 64 (92.8%) 7 (58.3%) 204 (91.9%) CSI, Cushing severity index; VTE, venous thromboembolism. One hundred forty-one patients had Cushing’s disease (64
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed
Search for other papers by Mari Minasyan in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
Introduction Cushing’s syndrome (CS) is a rare disease with an incidence ranging from 0.7 to 2.4 per million people per year ( 1 ). In contrast, venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep-vein thrombosis (DVT
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Simon Chang in
Google Scholar
PubMed
Search for other papers by Christian Fynbo Christiansen in
Google Scholar
PubMed
Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Search for other papers by Svend Juul in
Google Scholar
PubMed
Search for other papers by Anna-Marie B Münster in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
(interquartile range) 22.0 (22.0–22.0) 22.0 (22.0–22.0) – Venous thromboembolism (VTE) All VTE events ( n (%)) a 38 (3.3) 964 (0.9) – Events pr. 10,000 person-years (95% CI) 17.0 (12.4–23.4) 4.3 (4.0–4.6) 3.95 (2
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Malin Nylander in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Signe Frøssing in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Sven O Skouby in
Google Scholar
PubMed
endothelial dysfunction, which is associated with an increased risk of cardiovascular disease (CVD) ( 4 ). PCOS is associated with both CVD and venous thromboembolism (VTE). A recent meta-analysis found an odds ratio of 1.44 (1.13–1.84) for coronary heart
Search for other papers by Marc Blondon in
Google Scholar
PubMed
Search for other papers by Emmanuel Biver in
Google Scholar
PubMed
Search for other papers by Olivia Braillard in
Google Scholar
PubMed
Search for other papers by Marc Righini in
Google Scholar
PubMed
Search for other papers by Pierre Fontana in
Google Scholar
PubMed
Search for other papers by Alessandro Casini in
Google Scholar
PubMed
Introduction Thrombosis, collectively including ischemic heart disease, stroke and venous thromboembolism (VTE), causes more than one in four deaths worldwide ( 1 ). Venous thromboembolism itself is among the largest contributor of loss of
Faculté de Chirurgie Dentaire, Université de Toulouse III, Toulouse, France
Search for other papers by Emmanuelle Noirrit in
Google Scholar
PubMed
Search for other papers by Mélissa Buscato in
Google Scholar
PubMed
Search for other papers by Marion Dupuis in
Google Scholar
PubMed
CHU de Toulouse, Laboratoire d’Hématologie, Toulouse, France
Search for other papers by Bernard Payrastre in
Google Scholar
PubMed
Search for other papers by Coralie Fontaine in
Google Scholar
PubMed
Search for other papers by Jean-François Arnal in
Google Scholar
PubMed
Faculté de Chirurgie Dentaire, Université de Toulouse III, Toulouse, France
Search for other papers by Marie-Cécile Valera in
Google Scholar
PubMed
therapy (HRT) has been associated with adverse effects such as an increased incidence of breast cancer and thromboembolic events ( 1 , 2 , 3 ). Venous thromboembolism events (VTEs), which encompasses deep venous thrombosis (DVT) and pulmonary embolism
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Search for other papers by Laura P B Elbers in
Google Scholar
PubMed
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, the Netherlands
Search for other papers by Marije Wijnberge in
Google Scholar
PubMed
Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands
Search for other papers by Joost C M Meijers in
Google Scholar
PubMed
Search for other papers by Dennis C W Poland in
Google Scholar
PubMed
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Search for other papers by Dees P M Brandjes in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Search for other papers by Victor E A Gerdes in
Google Scholar
PubMed
.5–37.2) 0.10 27.8 (23.5–31.1) Currently smoking b ( n ) 4 0.51 11 1.00 6 Medical history Cardiovascular disease c ( n ) 11 0.68 18 0.77 12 Venous thromboembolism b ( n ) 2 0.49 2 0.52 0
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Internal Medicine, Lillebaelt Hospital, Kolding, Denmark
Search for other papers by Simon Chang in
Google Scholar
PubMed
Search for other papers by Arkadiusz J Goszczak in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed
Search for other papers by Jens Fedder in
Google Scholar
PubMed
Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Search for other papers by M Vakur Bor in
Google Scholar
PubMed
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Search for other papers by Moniek P M de Maat in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Search for other papers by Anna-Marie B Münster in
Google Scholar
PubMed
Introduction The risk of venous thromboembolism (VTE) among men born with Klinefelter syndrome (KS, 47,XXY) overall is increased more than four-fold ( 1 , 2 , 3 ). In particular, the relative risk of VTE in KS compared with the background
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Lukas Ochsner Ridder in
Google Scholar
PubMed
Department of Clinical Genetics and Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Agnethe Berglund in
Google Scholar
PubMed
Search for other papers by Kirstine Stochholm in
Google Scholar
PubMed
Unit for Thrombosis Research, Hospital of South West Jutland and University of Southern Denmark, Esbjerg, Denmark
Search for other papers by Simon Chang in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Unit for Thrombosis Research, Hospital of South West Jutland and University of Southern Denmark, Esbjerg, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
explained by an increased incidence of diseases of the circulatory system ( 12 , 66 , 67 ). For instance, men with KS present an up to eight-fold increased risk of death due to venous thromboembolisms (VTEs) compared to the male background population ( 68